TIAA CREF Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

TIAA CREF Investment Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-83,230	Closed	-$6.24M	–	3194
2015 Q3	$6.24M	Sell	83,230 -3,315	-4%	-$248K	﹤0.01%	1385
2015 Q2	$6.52M	Buy	86,545 +20,979	+32%	+$1.12M	﹤0.01%	1480
2015 Q1	$3.29M	Buy	65,566 +3,701	+6%	+$155K	﹤0.01%	1912
2014 Q4	$2.15M	Sell	61,865 -3,198	-5%	-$112K	﹤0.01%	2184
2014 Q3	$2.13M	Sell	65,063 -575	-0.9%	-$20.3K	﹤0.01%	2187
2014 Q2	$2.52M	Buy	65,638 +11,506	+21%	+$402K	﹤0.01%	2156
2014 Q1	$2.15M	Sell	54,132 -1,110	-2%	-$49.7K	﹤0.01%	2202
2013 Q4	$2.06M	Buy	55,242 +13,730	+33%	+$569K	﹤0.01%	2236
2013 Q3	$1.9M	Buy	41,512 +365	+0.9%	+$10.9K	﹤0.01%	2233
2013 Q2	$1.11M	Buy	+41,147	New	+$942K	﹤0.01%	2515

TIAA CREF Investment Management's KYTH Position: Q4 2015 in Review

TIAA CREF Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 83,230 shares — an estimated $6.24M sold.

TIAA CREF Investment Management first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $6.52M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

TIAA CREF Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
TIAA CREF Investment Management sold 83,230 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.24M.
TIAA CREF Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
TIAA CREF Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.52M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on TIAA CREF Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.